, China
/Stevepb from Pixabay

Taikang's robust capital to aid in business expansion: Fitch Ratings

Taikang Group’s profitability is supported by its value-driven business strategy.

Taikang Insurance Group Inc.’s (Taikang Group) is seen to sustain a solid capital buffer to support the expansion of its operating subsidiaries, thanks to surplus growth, according to Fitch Ratings.

The group's solvency ratio increased to 299% at the end of the first half of 2024, up from 285% at the end of 2023, significantly exceeding the regulatory minimum of 100%. 

Taikang Group’s profitability remains stable, supported by its value-driven business strategy.

The life insurance operation's new business value (NBV) margin remained steady in the first ten months of 2024, with a strong contribution from the agency channel and higher-margin bancassurance products.

Whilst net earnings in the first half of 2024 were lower compared to the same period in 2023, the group achieved a three-year average return on equity of 9.3%.

However, Fitch noted the China-based group’s continued exposure to risky assets, which remained high at 192% of shareholders’ equity in 2023, though this marks an improvement from 224% in 2022. 

Whilst this presents potential vulnerabilities, Fitch believes Taikang Group’s policies with participating features can absorb some market volatility.  

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.